Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial
- PMID: 31474119
- DOI: 10.1161/CIRCOUTCOMES.119.005805
Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial
Abstract
Background: Mobile health interventions may support risk factor management and are readily scalable in healthcare systems. We aim to evaluate the efficacy of a text messaging-based intervention to improve glycemic control in patients with coronary heart disease and diabetes mellitus in China.
Methods and results: The CHAT-DM study (Cardiovascular Health and Texting-Diabetes Mellitus) was a parallel-group, single-blind, randomized clinical trial that included 502 patients with both coronary heart disease and diabetes mellitus from 34 hospitals in China. The intervention group (n=251) received 6 text messages per week for 6 months in addition to usual care. Messages were theory driven and culturally tailored to provide educational and motivational information on glucose monitoring, blood pressure control, medication adherence, physical activity, and lifestyle. The control group (n=251) received usual care and 2 thank you messages per month. The primary outcome was change in glycated hemoglobin (HbA1C [hemoglobin A1C]) from baseline to 6 months. Secondary outcomes were change in proportion of patients achieving HbA1C <7%, fasting blood glucose, systolic blood pressure, LDL (low-density lipoprotein) cholesterol, body mass index, and physical activity from baseline to 6 months. The end points were assessed using analyses of covariance. The follow-up rate was 99%. When compared with control group at 6 months, the intervention group had a greater reduction in HbA1C (-0.2% versus 0.1%; P=0.003) and a greater proportion of participants who achieved HbA1C <7% (69.3% versus 52.6%; P=0.004). Change in fasting blood glucose was larger in the intervention group (between-group difference: -0.6 mmol/L; 95% CI, -1.1 to -0.2; P=0.011), but no other outcome differences were observed. Nearly all participants reported that messages were easy to understand (97.1%) and useful (94.1%).
Conclusions: A text message intervention resulted in better glycemic control in patients with diabetes mellitus and coronary heart disease. While the mechanism of this benefit remains to be determined, the results suggest that a simple, culturally sensitive mobile text messaging program may provide an effective and feasible way to improve disease self-management.
Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT02883842.
Keywords: coronary disease; diabetes mellitus; health behavior; risk factors; secondary prevention; text messaging.
Similar articles
-
Effect of Text Messaging on Risk Factor Management in Patients With Coronary Heart Disease: The CHAT Randomized Clinical Trial.Circ Cardiovasc Qual Outcomes. 2019 Apr;12(4):e005616. doi: 10.1161/CIRCOUTCOMES.119.005616. Circ Cardiovasc Qual Outcomes. 2019. PMID: 30998400 Clinical Trial.
-
Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes.BMJ Open. 2017 Dec 21;7(12):e018302. doi: 10.1136/bmjopen-2017-018302. BMJ Open. 2017. PMID: 29273661 Free PMC article. Clinical Trial.
-
Effect of Mobile Phone Text Messaging Self-Management Support for Patients With Diabetes or Coronary Heart Disease in a Chronic Disease Management Program (SupportMe) on Blood Pressure: Pragmatic Randomized Controlled Trial.J Med Internet Res. 2023 Jun 16;25:e38275. doi: 10.2196/38275. J Med Internet Res. 2023. PMID: 37327024 Free PMC article. Clinical Trial.
-
The effectiveness of patient activation intervention on type 2 diabetes mellitus glycemic control and self-management behaviors: A systematic review of RCTs.Prim Care Diabetes. 2020 Feb;14(1):12-20. doi: 10.1016/j.pcd.2019.08.009. Epub 2019 Sep 20. Prim Care Diabetes. 2020. PMID: 31543458
-
Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.J Manag Care Spec Pharm. 2016 May;22(5):493-515. doi: 10.18553/jmcp.2016.22.5.493. J Manag Care Spec Pharm. 2016. PMID: 27123912 Free PMC article.
Cited by
-
mHealth Technology and CVD Risk Reduction.Curr Atheroscler Rep. 2021 May 13;23(7):36. doi: 10.1007/s11883-021-00927-2. Curr Atheroscler Rep. 2021. PMID: 33983491 Review.
-
Feasibility and Potential Effectiveness of a Smartphone Zero-Time Exercise Intervention for Promoting Physical Activity and Fitness in Patients With Coronary Heart Disease: A Pilot Randomized Controlled Trial.Front Public Health. 2022 Jul 14;10:865712. doi: 10.3389/fpubh.2022.865712. eCollection 2022. Front Public Health. 2022. PMID: 35910893 Free PMC article. Clinical Trial.
-
User Engagement With mHealth Interventions to Promote Treatment Adherence and Self-Management in People With Chronic Health Conditions: Systematic Review.J Med Internet Res. 2024 Sep 24;26:e50508. doi: 10.2196/50508. J Med Internet Res. 2024. PMID: 39316431 Free PMC article.
-
Effect of social app-assisted education and support on glucose control in patients with coronary heart disease and diabetes mellitus.Front Cardiovasc Med. 2022 Sep 23;9:947130. doi: 10.3389/fcvm.2022.947130. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36211546 Free PMC article.
-
Technological Proficiencies, Engagement, and Practical Considerations for mHealth Programs at an Urban Safety-Net Hospital Emergency Departments: Data Analysis.JMIR Diabetes. 2022 Jun 6;7(2):e23641. doi: 10.2196/23641. JMIR Diabetes. 2022. PMID: 35666555 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous